MiR-25 and miR-92a regulate insulin i biosynthesis in rats

RNA Biology

Volumn 10, Issue 8, 2013, Pages 1365-1378

  Karolina, Dwi Setyowati ^a   Sepramaniam, Sugunavathi ^a   Tan, Hui Zhing ^a   Armugam, Arunmozhiarasi ^a   Jeyaseelan, Kandiah ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MONASH UNIVERSITY   (Australia)

Author keywords

3 untranslated region; Gene regulation; Hyperglycemia; Insulin biosynthesis; MicroRNAs

Indexed keywords

INSULIN; MESSENGER RNA; MICRORNA; MICRORNA 25; MICRORNA 32; MICRORNA 363; MICRORNA 9; MICRORNA 92A; MICRORNA 92B; POLYPYRIMIDINE TRACT BINDING PROTEIN; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

3' UNTRANSLATED REGION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; HUMAN; INSULIN SYNTHESIS; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; RNA BINDING; RNA STABILITY; UPREGULATION;

RATTUS;

3′ UNTRANSLATED REGION; GENE REGULATION; HYPERGLYCEMIA; INSULIN BIOSYNTHESIS; MICRORNAS;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; INSULIN; MICRORNAS; MOLECULAR SEQUENCE DATA; PANCREAS; POLYPYRIMIDINE TRACT-BINDING PROTEIN; RATS; RATS, WISTAR; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84883116249     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.25557     Document Type: Article

References (60)

1. Ashcroft SJ, Bunce J, Lowry M, Hansen SE, Hedeskov CJ. The effect of sugars on (pro)insulin biosynthesis. Biochem J 1978; 174:517-26; PMID:361036
2. Andrali SS, Sampley ML, Vanderford NL, Ozcan S. Glucose regulation of insulin gene expression in pancreatic beta-cells. Biochem J 2008; 415:1-10; PMID:18778246; http://dx.doi.org/10.1042/BJ20081029
3. Welsh M, Nielsen DA, MacKrell AJ, Steiner DF. Control of insulin gene expression in pancreatic betacells and in an insulin-producing cell line, RIN-5F cells. II. Regulation of insulin mRNA stability. J Biol Chem 1985; 260:13590-4; PMID:3902821
4. Poitout V, Hagman D, Stein R, Artner I, Robertson RP, Harmon JS. Regulation of the insulin gene by glucose and fatty acids. J Nutr 2006; 136:873-6; PMID:16549443
5. LeRoith D, Taylor SI, Olefsky JM. Diabetes Mellitus: A Fundamental and Clinical Text. Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo: Lippincott Williams and Wilkins, 2000.
6. Eizirik DL, Korbutt GS, Hellerström C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J Clin Invest 1992; 90:1263-8; PMID:1401063; http://dx.doi.org/10. 1172/JCI115989
7. Robertson RP, Zhang HJ, Pyzdrowski KL, Walseth TF. Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest 1992; 90:320-5; PMID:1644911; http://dx.doi.org/10.1172/JCI115865
8. Marshak S, Leibowitz G, Bertuzzi F, Socci C, Kaiser N, Gross DJ, et al. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 1999; 48:1230-6; PMID:10342809; http://dx.doi.org/10.2337/diabetes.48.6.1230
9. Khoo S, Griffen SC, Xia Y, Baer RJ, German MS, Cobb MH. Regulation of insulin gene transcription by ERK1 and ERK2 in pancreatic beta cells. J Biol Chem 2003; 278:32969-77; PMID:12810726; http://dx.doi.org/10.1074/jbc.M301198200
10. Docherty HM, Hay CW, Ferguson LA, Barrow J, Durward E, Docherty K. Relative contribution of PDX-1, MafA and E47/beta2 to the regulation of the human insulin promoter. Biochem J 2005; 389:813-20; PMID:15862113; http://dx.doi.org/10.1042/BJ20041891
11. Lawrence MC, McGlynn K, Park BH, Cobb MH. ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter. J Biol Chem 2005; 280:26751-9; PMID:15899886; http://dx.doi.org/10.1074/jbc.M503158200
12. Giddings SJ, Chirgwin J, Permutt MA. Evaluation of rat insulin messenger RNA in pancreatic and extrapancreatic tissues. Diabetologia 1985; 28:343-7; PMID:2412922; http://dx.doi.org/10.1007/BF00283141
13. Leibiger B, Moede T, Schwarz T, Brown GR, Köhler M, Leibiger IB, et al. Short-term regulation of insulin gene transcription by glucose. Proc Natl Acad Sci USA 1998; 95:9307-12; PMID:9689076; http://dx.doi.org/10.1073/pnas.95. 16.9307
14. Leibiger B, Wahlander K, Berggren PO, Leibiger IB. Glucose-stimulated insulin biosynthesis depends on insulin-stimulated insulin gene transcription. J Biol Chem 2000; 275:30153-6; PMID:10913151; http://dx.doi.org/10.1074/jbc. M005216200
15. Wicksteed B, Herbert TP, Alarcon C, Lingohr MK, Moss LG, Rhodes CJ. Cooperativity between the preproinsulin mRNA untranslated regions is necessary for glucose-stimulated translation. J Biol Chem 2001; 276:22553-8; PMID:11297542; http://dx.doi.org/10.1074/jbc.M011214200
16. Tillmar L, Carlsson C, Welsh N. Control of insulin mRNA stability in rat pancreatic islets. Regulatory role of a 3′-untranslated region pyrimidine-rich sequence. J Biol Chem 2002; 277:1099-106; PMID:11696543; http://dx.doi.org/10.1074/jbc.M108340200
17. Fred RG, Tillmar L, Welsh N. The role of PTB in insulin mRNA stability control. Curr Diabetes Rev 2006; 2:363-6; PMID:18220641; http://dx.doi.org/10. 2174/157339906777950570
18. Roush SF, Slack FJ. Micromanagement: a role for microRNAs in mRNA stability. ACS Chem Biol 2006; 1:132-4; PMID:17163657; http://dx.doi.org/10. 1021/cb600138j
19. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010; 79:351-79; PMID:20533884; http://dx.doi.org/10.1146/annurevbiochem-060308-103103
20. Tang X, Muniappan L, Tang G, Ozcan S. Identification of glucose-regulated miRNAs from pancreatic beta cells reveals a role for miR-30d in insulin transcription. RNA 2009; 15:287-93; PMID:19096044; http://dx.doi.org/10.1261/ rna.1211209
21. Melkman-Zehavi T, Oren R, Kredo-Russo S, Shapira T, Mandelbaum AD, Rivkin N, et al. miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. EMBO J 2011; 30:835-45; PMID:21285947; http://dx.doi.org/10.1038/emboj.2010.361
22. Zhao X, Mohan R, Özcan S, Tang X. MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic β-cells. J Biol Chem 2012; 287:31155-64; PMID:22733810; http://dx.doi.org/10.1074/jbc.M112.362632
23. Jacovetti C, Abderrahmani A, Parnaud G, Jonas JC, Peyot ML, Cornu M, et al. MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity. J Clin Invest 2012; 122:3541-51; PMID:22996663; http://dx.doi.org/10.1172/JCI64151
24. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 2006; 281:26932-42; PMID:16831872; http://dx.doi.org/10.1074/jbc.M601225200
25. Giddings SJ, Chirgwin J, Permutt MA. Effects of glucose on proinsulin messenger RNA in rats in vivo. Diabetes 1982; 31:624-9; PMID:6761201; http://dx.doi.org/10.2337/diabetes.31.7.624
26. Karolina DS, Armugam A, Tavintharan S, Wong MT, Lim SC, Sum CF, et al. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One 2011; 6:e22839; PMID:21829658; http://dx.doi.org/10.1371/journal.pone.0022839
27. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000; 49:1390-4; PMID:11092499; http://dx.doi.org/10.1053/meta.2000. 17721
28. Fred RG, Bang-Berthelsen CH, Mandrup-Poulsen T, Grunnet LG, Welsh N. High glucose suppresses human islet insulin biosynthesis by inducing miR-133a leading to decreased polypyrimidine tract binding protein-expression. PLoS One 2010; 5:e10843; PMID:20520763; http://dx.doi.org/10.1371/journal.pone.0010843
29. Altirriba J, Barbera A, Del Zotto H, Nadal B, Piquer S, Sánchez-Pla A, et al. Molecular mechanisms of tungstate-induced pancreatic plasticity: a transcriptomics approach. BMC Genomics 2009; 10:406; PMID:19715561; http://dx.doi.org/10.1186/1471-2164-10-406
30. McClenaghan NH, Barnett CR, Ah-Sing E, Abdel-Wahab YH, O'Harte FP, Yoon TW, et al. Characterization of a novel glucose-responsive insulinsecreting cell line, BRIN-BD11, produced by electrofusion. Diabetes 1996; 45:1132-40; PMID:8690162; http://dx.doi.org/10.2337/diabetes.45.8.1132
31. Efrat S. Development of engineered pancreatic betacell lines for cell therapy of diabetes. Adv Drug Deliv Rev 1998; 33:45-52; PMID:10837652; http://dx.doi.org/10.1016/S0169-409X(98)00019-2
32. Limbert C, Päth G, Jakob F, Seufert J. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus. Diabetes Res Clin Pract 2008; 79:389-99; PMID:17854943; http://dx.doi.org/10. 1016/j.diabres.2007.06.016
33. Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ, Liu ZM. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract 2011; 91:94-100; PMID:21146880; http://dx.doi.org/10. 1016/j.diabres.2010.11.006
34. Narushima M, Kobayashi N, Okitsu T, Tanaka Y, Li SA, Chen Y, et al. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol 2005; 23:1274-82; PMID:16186810; http://dx.doi.org/10.1038/nbt1145
35. Gartner W, Koc F, Nabokikh A, Daneva T, Niederle B, Luger A, et al. Long-term in vitro growth of human insulin-secreting insulinoma cells. Neuroendocrinology 2006; 83:123-30; PMID:16888402; http://dx.doi.org/10.1159/ 000094875
36. Labriola L, Peters MG, Krogh K, Stigliano I, Terra LF, Buchanan C, et al. Generation and characterization of human insulin-releasing cell lines. BMC Cell Biol 2009; 10:49; PMID:19545371; http://dx.doi.org/10.1186/1471-2121-10-49
37. Ravassard P, Hazhouz Y, Pechberty S, Bricout-Neveu E, Armanet M, Czernichow P, et al. A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion. J Clin Invest 2011; 121:3589-97; PMID:21865645; http://dx.doi.org/10.1172/JCI58447
38. Guo-Parke H, McCluskey JT, Kelly C, Hamid M, McClenaghan NH, Flatt PR. Configuration of electrofusion-derived human insulin-secreting cell line as pseudoislets enhances functionality and therapeutic utility. J Endocrinol 2012; 214:257-65; PMID:22685334; http://dx.doi.org/10.1530/JOE-12-0188
39. Rosero S, Bravo-Egana V, Jiang Z, Khuri S, Tsinoremas N, Klein D, et al. MicroRNA signature of the human developing pancreas. BMC Genomics 2010; 11:509; PMID:20860821; http://dx.doi.org/10.1186/1471-2164-11-509
40. Chu K, Tsai MJ. Neuronatin, a downstream target of BETA2/NeuroD1 in the pancreas, is involved in glucose-mediated insulin secretion. Diabetes 2005; 54:1064-73; PMID:15793245; http://dx.doi.org/10.2337/diabetes.54.4.1064
41. Gu C, Stein GH, Pan N, Goebbels S, Hörnberg H, Nave KA, et al. Pancreatic beta cells require NeuroD to achieve and maintain functional maturity. Cell Metab 2010; 11:298-310; PMID:20374962; http://dx.doi.org/10.1016/ j.cmet.2010.03.006
42. Sharma A, Moore M, Marcora E, Lee JE, Qiu Y, Samaras S, et al. The NeuroD1/BETA2 sequences essential for insulin gene transcription colocalize with those necessary for neurogenesis and p300/CREB binding protein binding. Mol Cell Biol 1999; 19:704-13; PMID:9858593
43. Kaneto H, Nakatani Y, Miyatsuka T, Matsuoka TA, Matsuhisa M, Hori M, et al. PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance. Diabetes 2005; 54:1009-22; PMID:15793239; http://dx.doi.org/10.2337/diabetes.54.4.1009
44. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009; 324:1710-3; PMID:19460962; http://dx.doi.org/10.1126/ science.1174381
45. Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003; 23:117-45; PMID:12500286; http://dx.doi.org/10.1002/med.10024
46. Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012; 2012:918267; PMID:22611498; http://dx.doi.org/10.1155/2012/918267
47. Razumilava N, Bronk SF, Smoot RL, Fingas CD, Werneburg NW, Roberts LR, et al. miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma. Hepatology 2012; 55:465-75; PMID:21953056; http://dx.doi.org/10.1002/hep.24698
48. Zhang H, Zuo Z, Lu X, Wang L, Wang H, Zhu Z. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. Oncol Rep 2012; 27:594-8; PMID:22076535
49. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, et al. A pancreatic isletspecific microRNA regulates insulin secretion. Nature 2004; 432:226-30; PMID:15538371; http://dx.doi.org/10.1038/nature03076
50. Ehehalt F, Knoch K, Erdmann K, Krautz C, Jäger M, Steffen A, et al. Impaired insulin turnover in islets from type 2 diabetic patients. Islets 2010; 2:30-6; PMID:21099291; http://dx.doi.org/10.4161/isl.2.1.10098
51. Støy J, Edghill EL, Flanagan SE, Ye H, Paz VP, Pluzhnikov A, et al.; Neonatal Diabetes International Collaborative Group. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci USA 2007; 104:15040-4; PMID:17855560; http://dx.doi.org/10.1073/pnas.0707291104
52. Liu M, Hodish I, Haataja L, Lara-Lemus R, Rajpal G, Wright J, et al. Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth. Trends Endocrinol Metab 2010; 21:652-9; PMID:20724178; http://dx.doi.org/10. 1016/j.tem.2010.07.001
53. Liu M, Lara-Lemus R, Shan SO, Wright J, Haataja L, Barbetti F, et al. Impaired cleavage of preproinsulin signal peptide linked to autosomal-dominant diabetes. Diabetes 2012; 61:828-37; PMID:22357960; http://dx.doi.org/10.2337/ db11-0878
54. Hausser J, Syed AP, Bilen B, Zavolan M. Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation. Genome Res 2013; 23:604-15; PMID:23335364; http://dx.doi.org/10.1101/gr.139758.112
55. van de Bunt M, Gaulton KJ, Parts L, Moran I, Johnson PR, Lindgren CM, et al. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS One 2013; 8:e55272; PMID:23372846; http://dx.doi.org/10.1371/journal.pone.0055272
56. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, et al.; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010; 42:579-89; PMID:20581827; http://dx.doi.org/10.1038/ng.609
57. Wang H, Lin YZ, Zhou Y, Lu HM, Lu SH, Luo C, et al. Circulatory level of microRNA 92a in patients of stable angina pectoris with diabetes mellitus. China Journal of Modern Medicine 2011; 23:718-22
58. Sepramaniam S, Armugam A, Lim KY, Karolina DS, Swaminathan P, Tan JR, et al. MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia. J Biol Chem 2010; 285:29223-30; PMID:20628061; http://dx.doi.org/10.1074/jbc.M110.144576
59. Wu JJ, Quijano C, Chen E, Liu H, Cao L, Fergusson MM, et al. Mitochondrial dysfunction and oxidative stress mediate the physiological impairment induced by the disruption of autophagy. Aging (Albany NY) 2009; 1:425-37; PMID:20157526
60. Su JL, Kilpatrick KE, Champion BR, Morris DC, Lehmann JM, Kost TA. Fluorescent microtiter screening assay for immunocytochemically reactive antibodies. Biotechniques 1997; 22:320-4; PMID:9043705